Adherence to human host cells is considered the pivotal first step in the pathogenesis of hematogenous infections caused by Candida species. However, an understanding of the adherence mechanisms of Candida species as related to their outer cellular components is only in the initial stages.
The cell wall of Candida species consists of proteins, glucans, mannans, and chitin (4, 15) . These components have been evaluated individually for their role as potential adhesins by different investigative groups. Certain evidence points to mannosylated proteins serving as adhesins for many of the cell types studied. (i) preincubation of Candida species with concanavalin A (ConA), which binds to and presumably blocks alpha-linked D-mannose residues, decreases adherence (25) (26) (27) (28) , (ii) mannosylated proteins from culture supernatants inhibit adherence (21) , and (iii) tunicamycin, a mannosylated protein synthesis inhibitor, decreases adherence (5, 18) . Evidence for proteins serving as adhesins is derived from two types of studies: (i) treatment of Candida species with protein-denaturing substances, such as proteolytic enzymes (19, 30) or mercaptoethanol and dithiothreitol (19) , decreases adherence; and (ii) glycosidases, lipases, salts, or detergents have little effect (19) . Additionally, Segal and Savage (29) found that chitin-soluble extracts reduced the adherence of Candida albicans to epithelial cells.
This report continues our investigations into the mechanisms of adherence of Candida species to human vascular endothelial cells from the perspective of understanding how Candida species escape the intravascular compartment to infect target organs. In the experiments reported here, we studied Candida germ tubes as well as blastospores, since increased adherence of the germinated phase to host cells has been shown (16, 24) . Additionally, certain molecules on Candida germ tubes have characteristics of both complement receptor 2 (CR2) and CR3 found on human host cells (2, 6, 7, 10, 11, 13 (6) and may be important in the adherence of C. albicans to endothelial cells (12) . These receptors may also be present on blastospores of the organism (11) .
In the studies described here, we used an approach complementary to (20, 22) . Electrophoresis was carried out in a minigel system (Bio-Rad Laboratories, Richmond, Calif.). The total amount of protein loaded per lane was 3 ,ug for each of the test preparations. Western blotting was performed with either a serum sample from a patient with chronic mucocutaneous candidiasis or a monoclonal antibody (MAb) to either human CR3 (OKM-1) or the C. albicans C3d-binding protein (CA-A). The primary antibody was diluted 1:400 for immunoblotting of extracts. Binding of the primary antibody to C. albicans antigens was detected with alkaline phosphatase-labeled protein A as described previously (20, 22) .
Preparation of cells for adherence assays. C. albicans ATCC 36082 (American Type Culture Collection, Rockville, Md.) was maintained on yeast extract (Difco Laboratories, Detroit, Mich.)-glucose-potassium phosphate agar slants at 4°C. Prior to experiments, it was grown in yeast nitrogen base broth (Difco) supplemented with 1% glucose (J. T. Baker Chemical Co., Phillipsburg, N.J.) and 0.15% L-asparagine (Calbiochem, San Diego, Calif.). Organisms were inoculated from the modified agar slants into yeast nitrogen base broth for overnight culturing on a rotating drum at 27°C. An aliquot of the overnight culture was inoculated into fresh yeast nitrogen base broth and incubated. The stationaryphase organisms were sonicated for 3 s (setting no. 4; model 350 sonicator; Branson Sonic Power Co., Danbury, Conn.) to yield a suspension of >90% singlet blastoconidia as previously described (8) . Viability (determined by trypan blue exclusion) was unaltered by sonication. The singlet suspension was centrifuged at 700 x g (Sorvall RC-3 centrifuge) for 7 min and washed twice with 0.85% NaCl. The cells were resuspended in Dulbecco's PBS, sonicated for 3 s, and counted with a hemacytometer. For the enzyme-linked immunosorbent assay (ELISA) with blastospores, organisms were adjusted to 2 x 106/ml. For the ELISA with germ tubes, blastoconidia were first adjusted to 107 in 10 ml of germination medium (0.075% gelatin and 0.15% sucrose in distilled water) and then incubated at 37°C until the germ tube length was approximately equal to the yeast cell diameter. Germ tubes were sonicated for 3 s, counted with a hemacytometer, and adjusted to 6 x 105/ml for the adherence assays.
Endothelial cell monolayers. Human umbilical vein endothelial cells were obtained by use of minor modifications of the method of Jaffe (14) . They were grown to confluence from a primary culture in 25-cm2 tissue culture flasks and split into 96-well microtiter plates (Costar, Van Nuys, Calif.) for the ELISAs. Cells were grown in the presence of extracellular growth factor (Bionetics, Rockville, Md.) at a concentration of 0.12 mg/ml in medium M-199 (GIBCO, Grand Island, N.Y.). The microtiter wells were coated with 0.01 mg of fibronectin (Collaborative Research, Bedford, Mass.) per ml prior to plating of the endothelial cells. Trypsin (0.018% in 0.85% NaCl; Sigma) was used to transfer the cells from primary flasks to the microtiter wells.
ELISA reagents. A single MAb conjugated to alkaline phosphatase was used for the ELISA in a modification of our previously published assay (8) . The MAb was an antiCandida mannan immunoglobulin, CDE344.3-AP (Hybritech, San Diego, Calif.), diluted in 1% bovine serum albumin (BSA)-1% Tween 20 in calcium-and magnesiumfree PBS (pH 7.35). Blocking buffer against the anti-Candida mannan MAb was 1% BSA-0.1% Tween 20 in PBS (pH 7.2).
ELISA. The endothelial cells were washed twice with 37°C sterile PBS by gentle pipetting in and aspirating out with a Pasteur pipette. The microtiter plates were held vertically for both washes. Two controls were used: endothelial cells with antibodies but no C. albicans cells and endothelial cells with no antibodies or C albicans cells. One hundred microliters of 37°C PBS was added to the control wells. The wells used for testing of the potential blockers received 50 ,ul of a 400-,ug/ml concentration of a potential blocker or 50 ,ul of PBS plus 50 ,ul of a 2x concentration of C. albicans. The final concentration of C. albicans was 3 x 104 cells per well, and that of the possible blocker was 200 ,ug/ml. A control column of eight wells containing a potential blocker plus PBS but no C. albicans cells was also included. This control served as an indicator of cross-reactivity between the cell wall extract and MAb CDE344.3-AP. Neither fraction I nor fraction II was cross-reactive. All columns (of eight replicates each) were tested in duplicate: one set to be rinsed and one set nonrinsed. The nonrinsed wells were used to determine the optical density (OD) of the total number of organisms added to each well. The microtiter plates were incubated for 30 min (in room air) at 37°C.
After incubation, the C albicans suspension from one set of columns (potential blocker plus PBS, C. albicans plus PBS, and potential blocker plus C. albicans) was aspirated and the wells were rinsed four times with 37°C PBS (75 ,ul per rinse). The plates were centrifuged for 10 min at 200 x g, and the contents of the nonrinsed wells were aspirated. The cells were fixed for several hours in 45 ,ul of 2% paraformaldehyde at 4°C.
Following fixation, the wells were washed three times with 50 ,ul of 1% BSA-0.1% Tween 20. Fifty microliters of 37°C MAb CDE344.3-AP was added to each well. The plates were incubated at 37°C for 60 min. (Fig.  1, lane 3) . Fraction I was also tested with MAbs to mammalian CR3 (MAb OKM-1) (Fig. 1, lane 4) and to the C. albicans C3d-binding protein (MAb CA-A) (Fig. 1, lane 5 
RESULTS
Effects of cell wall fractions on adherence. A whole-cell hyphal extract was initially fractionated with ConA-Sepharose. Soluble, nonbinding proteins (fraction I) and a-methylmannoside-eluted proteins (fraction II) were assayed for their effects on the adherence of germ tubes or blastospores to human endothelial cells. Fraction I at a concentration of 200 ,ug/ml inhibited the adherence of germ tubes by 50% +-23% (P < 0.001), compared with the adherence of germ tubes in controls. In contrast, fraction II, which contained mannan and mannosylated proteins, was not inhibitory (10% + 21% inhibition; P > 0. 5 [not significant]). These same fractions at 200 p,g/ml were also tested for their effects on the adherence of blastospores to human endothelial cells. Fraction I inhibited the adherence of blastospores by 41% + 26% (P < 0.001). Fraction II was also inhibitory (27% 16% inhibition; P < 0.001). Although there were significant day-to-day differences in the magnitude of the blocking ability of each fraction, fraction I always blocked both blastospore and germ tube adherence to endothelial cells, and fraction II always blocked blastospore but not germ tube adherence.
Western blot analysis. Fraction I was analyzed by SDS-PAGE and Western blotting (Fig. 1) . A number of bands were observed in Aurodye-stained gels and nitrocellulose transfers from gels. The major bands ranged in molecular mass from 95 to 25 kDa (Fig. 1, lane 2) . When a serum In 1985, Heidenreich and Dierich (13) found that sheep erythrocytes coated with complement component iC3b or C3d bound to C. albicans and C. stellatoidea hyphae, suggesting the presence of CR2-and CR3-like molecules on the surface of the organisms. This finding was confirmed by Edwards et al. (6) , and the recognition of the hyphal or germ tube antigen by an MAb (Mo-i) directed against human CR3 was established. CR3 is known to be important in the adherence of leukocytes to endothelium (1, 23) , and the possibility that the CR3-like molecules on the surface of germinated Candida cells may be operative in the adherence of the germinated form to endothelial cells remains open to further investigation.
More recently, the similarity between Candida and human complement receptors has been further determined. Gilmore et al. (11) found on C. albicans blastospores surface receptors for iC3b that shared homology with the alpha chain (CDiib) of human CR3 but not the beta chain (CD18). Calderone et al. (2) found receptors for both iC3b and C3d on C. albicans hyphae but not blastospores, and they extracted fractions that inhibited the rosetting of C3d-coated erythrocytes. Eigentler et al. (7) concluded that human CR3 and C. albicans complement receptors were antigenically related but not identical on the basis of anti-CR3 MAb binding. In their studies, an anti-CR3 MAb (OKM-1) was blocked from binding to C. albicans germ tubes when the cells were first reacted with an anti-Candida antibody that presumably bound to CR3-like molecules on the hyphae. However, an F(ab')2 fragment of this anti-Candida immunoglobulin G was antigenically too different to bind directly to the true CR3 site found on a macrophage cell line (U-937).
On the basis of the experimental data that we are presenting now, we have identified a protein fraction extracted from C. albicans that blocks the adherence of the germinated form of the organism to human vascular endothelial cells. While this fraction contains constituents that react with an anti-CR3 MAb, OKM-1, blocking studies with purified C. albicans CR3-like molecules need to be pursued. There is additional evidence for a role of CR3-like molecules as adhesins for C. albicans. Frey et al. (9) and Gustafson et al. (12) showed that the iC3b ligand blocked the adherence of C. albicans to cultured endothelial cells, and Klotz and Smith (17) demonstrated that the adherence of C. albicans to subendothelium was inhibited by RGD peptides, which are common to ligands such as iC3b. Additionally, Gustafson et al. (12) (20) . In this study, blocking (of germ tube adherence) was associated with the nonmannosylated fraction of whole-cell extracts, perhaps indicating that these activities are actually associated with different proteins. Ollert et al. have shown that a mutant of C. albicans deficient in adherence has normal CR2-like molecule activity but substantially reduced CR3-like molecule activity (22) .
We conclude also that the surface of the blastospore form has at least one additional determinant not present on the hyphal form, since a component(s) from both fraction I and fraction II blocked the adherence of blastospores, while a compent from only fraction I blocked the adherence of germinated organisms. Recently, Critchley and Douglas (5) described an adhesin of C albicans blastospores for epithelial cells that appeared to be a lectinlike protein that recognized fucose residues of host cells. This adhesin appears to be different from the CR3-like component of C. albicans, which recognizes peptide sequences. Thus, blastospores may contain both types of adhesins.
In conclusion, we found that fraction II blocked only blastospore adherence to endothelial cells, while fraction I blocked both blastospore and germ tube adherence to endothelium. Since the two fractions had dissimilar effects on the adherence of blastospores and germ tubes, the adherence mechanisms of the two forms of C. albicans are not identical. Fraction II contains mannosylated proteins, which may block constituents not present on germ tubes by a mechanism different from that of the proteins of fraction I. Fraction I contains proteins that have a low carbohydrate content, that also react with OKM-1 and CA-A, and that therefore may be CR2-or CR3-like proteins. The fact that both the soluble proteins (fraction I) and the mannosylated proteins (fraction II) blocked adherence, coupled with the lack of blocking by pure mannan (24), points to both proteins and the protein moiety of mannosylated proteins as being adhesins. Further studies are necessary to characterize the similarities and differences between these CR2-or CR3-like proteins on C. albicans and the human proteins.
